TG Therapeutics, Inc. (TGTX)
56.05
+1.78
(+3.28%)
USD |
NASDAQ |
Aug 24, 16:00
56.45
+0.40
(+0.71%)
After-Hours: 20:00
TG Therapeutics Price to Book Value : 14.20 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 13.75 |
| August 20, 2026 | 12.81 |
| August 19, 2026 | 13.10 |
| August 18, 2026 | 12.74 |
| August 17, 2026 | 12.49 |
| August 14, 2026 | 12.35 |
| August 13, 2026 | 12.15 |
| August 12, 2026 | 12.54 |
| August 11, 2026 | 12.64 |
| August 10, 2026 | 12.46 |
| August 07, 2026 | 12.61 |
| August 06, 2026 | 12.56 |
| August 05, 2026 | 12.64 |
| August 04, 2026 | 12.35 |
| August 03, 2026 | 11.70 |
| July 31, 2026 | 13.18 |
| July 30, 2026 | 13.56 |
| July 29, 2026 | 13.55 |
| July 28, 2026 | 13.90 |
| July 27, 2026 | 14.13 |
| July 24, 2026 | 14.20 |
| July 23, 2026 | 14.06 |
| July 22, 2026 | 13.35 |
| July 21, 2026 | 13.67 |
| July 20, 2026 | 13.67 |
| Date | Value |
|---|---|
| July 17, 2026 | 13.90 |
| July 16, 2026 | 13.92 |
| July 15, 2026 | 14.29 |
| July 14, 2026 | 13.91 |
| July 13, 2026 | 13.94 |
| July 10, 2026 | 14.47 |
| July 09, 2026 | 14.97 |
| July 08, 2026 | 14.50 |
| July 07, 2026 | 14.71 |
| July 06, 2026 | 14.06 |
| July 02, 2026 | 13.51 |
| July 01, 2026 | 13.56 |
| June 30, 2026 | 13.92 |
| June 29, 2026 | 14.63 |
| June 26, 2026 | 14.66 |
| June 25, 2026 | 14.08 |
| June 24, 2026 | 14.07 |
| June 23, 2026 | 14.16 |
| June 22, 2026 | 14.28 |
| June 18, 2026 | 13.97 |
| June 17, 2026 | 13.52 |
| June 16, 2026 | 13.27 |
| June 15, 2026 | 13.21 |
| June 12, 2026 | 13.00 |
| June 11, 2026 | 12.61 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Krystal Biotech, Inc. | 7.442 |
| MAIA Biotechnology, Inc. | 3.986 |
| Vericel Corp. | 5.857 |
| Incyte Corp. | 4.054 |
| Regeneron Pharmaceuticals, Inc. | 2.702 |
Price to Book Value Related Metrics
| PE Ratio | 20.41 |
| PS Ratio | 11.18 |
| PEG Ratio | 0.0322 |
| Price to Free Cash Flow | 514.00 |
| Price | 56.05 |
| Earnings Yield | 4.90% |
| Market Cap | 8.580B |
| PEGY Ratio | 0.0322 |
| Operating PE Ratio | 65.55 |
| Normalized PE Ratio | 20.03 |